Global Cord Blood Corporation Announces Entry into Cell Therapy Market by Acquiring Cellenkos and Its Products Rights

HONG KONG, April 30, 2022 /PRNewswire/ -- Global Cord Blood Corporation Announces Entry into Cell Therapy Market by Acquiring Cellenkos and Its Products Rights

Related Keywords

China ,Texas ,United States ,Cellenko Tregs ,Simrit Parmar ,Incyte Corporation Nasdaq ,Cellenkos Inc ,Strategic Development Agreement ,Global Cord Blood Corporation ,Board Of Directors The Company ,Incyte Corporation ,Anderson Cancer Centre ,Coronavirus Disease ,Acute Respiratory Distress Syndrome ,Amyotrophic Lateral Sclerosis ,Aplastic Anemia ,Placebo Controlled Safety ,Early Efficacy Trial ,Emergency Use Authorization ,Breakthrough Therapy Designation ,Fast Track Designation ,Orphan Drug Designation ,Ting Zheng ,Cord Blood Corporation ,Immunet Regulatory Cell Therapies ,Treat Autoimmune Diseases ,Global Cord Blood Corporation Announces Entry Into Cell Therapy Market By Acquiring Cellenkos And Its Products Rights ,